Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland · Delayed Price · Currency is PLN 70.50
-0.20 (-0.28%)
Aug 6, 2026, 9:14 AM CET
WSE:CTX Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.35 | 10.72 | 39.26 | 75.7 | 70.99 | 117.94 |
Short-Term Investments | 15.54 | 21.39 | - | - | 19.98 | - |
Cash & Short-Term Investments | 17.89 | 32.11 | 39.26 | 75.7 | 90.97 | 117.94 |
Cash Growth | -70.88% | -18.21% | -48.14% | -16.78% | -22.87% | 1007.03% |
Accounts Receivable | 2.32 | 1.22 | 38.25 | 12.57 | 9.67 | 11.71 |
Other Current Assets | 0.4 | 0.5 | 0.58 | 0.38 | 0.76 | 0.91 |
Total Current Assets | 20.61 | 33.82 | 78.09 | 88.65 | 101.39 | 130.56 |
Net Property, Plant & Equipment | 4.31 | 4.91 | 7.86 | 6.95 | 8.35 | 12.61 |
Other Intangible Assets | 1.08 | 1.18 | 1.4 | 1.47 | 0.78 | 0.36 |
Other Long-Term Assets | 0.1 | 0.11 | 0.15 | 0.22 | 0.08 | 0.01 |
Total Assets | 26.1 | 40.02 | 87.5 | 97.29 | 110.6 | 143.54 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4.73 | 4.39 | 5.77 | 8.34 | 7.81 | 4.74 |
Current Portion of Leases | 2.13 | 2.06 | 2.75 | 2.53 | 3.25 | 5.24 |
Other Current Liabilities | 6 | 8.47 | 11.51 | 15.86 | 1.79 | 6.39 |
Total Current Liabilities | 12.87 | 14.91 | 20.03 | 26.73 | 12.84 | 16.37 |
Long-Term Leases | 1.06 | 1.52 | 2.89 | 1.25 | 1.38 | 2.94 |
Other Long-Term Liabilities | 0.12 | 0.12 | 0.1 | 0.1 | 0.05 | 0.03 |
Total Long-Term Liabilities | 1.17 | 1.63 | 2.99 | 1.34 | 1.43 | 2.97 |
Total Liabilities | 14.04 | 16.54 | 23.02 | 28.07 | 14.27 | 19.34 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.56 | 0.55 | 0.55 | 0.47 | 0.42 | 0.41 |
Additional Paid-in Capital | 267.79 | 267.85 | 266.85 | 233.25 | 189.82 | 181.81 |
Accumulated Other Comprehensive Income | 0.2 | 0.19 | 0.19 | 0.19 | 0.18 | 0.19 |
Retained Earnings | -256.48 | -245.11 | -203.11 | -164.69 | -94.08 | -58.21 |
Shareholders' Equity | 12.05 | 23.48 | 64.47 | 69.22 | 96.33 | 124.2 |
Total Liabilities & Equity | 26.1 | 40.02 | 87.5 | 97.29 | 110.6 | 143.54 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.19 | 3.58 | 5.64 | 3.78 | 4.62 | 8.18 |
Net Cash (Debt) | 14.69 | 28.53 | 33.62 | 71.93 | 86.34 | 109.76 |
Net Cash Growth | -74.10% | -15.13% | -53.26% | -16.70% | -21.34% | - |
Net Cash Per Share | 2.66 | 5.17 | 7.21 | 15.08 | 19.82 | 25.20 |
Book Value | 12.05 | 23.48 | 64.47 | 69.22 | 96.33 | 124.2 |
Book Value Per Share | 2.18 | 4.26 | 13.84 | 14.51 | 22.11 | 28.51 |
Tangible Book Value | 10.98 | 22.3 | 63.07 | 67.75 | 95.55 | 123.84 |
Tangible Book Value Per Share | 1.98 | 4.04 | 13.54 | 14.20 | 21.93 | 28.43 |